Cannabix TechnologiesBLOZF +4.85%34 Quick Ratio is 5.99 as of Jan. 2026, which is 90% below its 10-year median of 59.08. GuruFocus rates BLOZF with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Cannabix Technologies ranks better than 86.87% on this metric.
Cannabix Technologies has a quick ratio of 5.99. It generally indicates good short-term financial strength.
The historical rank and industry rank for Cannabix Technologies's Quick Ratio or its related term are showing as below:
BLOZF'
s Quick Ratio Range Over the Past 10 Years
Min: 5.99 Med: 59.08 Max: 532.2
Current: 5.99
During the past 13 years, Cannabix Technologies's highest Quick Ratio was 532.20. The lowest was 5.99. And the median was 59.08.
BLOZF's Quick Ratio is ranked better than 86.87% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs BLOZF: 5.99
Cannabix Technologies (OTCPK:BLOZF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Cannabix Technologies Quick Ratio Related Terms
Cannabix Technologies Quick Ratio Historical Data
* Premium members only.
The historical data trend for Cannabix Technologies's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cannabix Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Cannabix Technologies's Quick Ratio for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabix Technologies (BLOZF) has a Quick Ratio of 5.99 as of Jan. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Cannabix Technologies and its competitors. This is 90% below median its historical median of 59.08. Over the past decade, Cannabix Technologies' Quick Ratio has ranged from 5.99 to 532.20. According to the industry distribution chart, Cannabix Technologies ranks #112 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 13.1%.
Is Cannabix Technologies' Quick Ratio too high?
Cannabix Technologies' current Quick Ratio of 5.99 is 90% below median its 10-year median of 59.08. Over the past 10 years, this metric has ranged from a low of 5.99 to a high of 532.20. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Cannabix Technologies' value of 5.99 is 216.9% above this industry median. Based on the distribution chart, Cannabix Technologies ranks #112 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cannabix Technologies has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #112 out of 853 companies for Quick Ratio. This places Cannabix Technologies in the top 13% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Cannabix Technologies' value of 5.99 is 216.9% above this benchmark. Historically, Cannabix Technologies' own Quick Ratio has ranged from 5.99 to 532.20 over the past decade. While the company's 10-year median is 59.08 vs. the industry median of 1.89, Cannabix Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabix Technologies's current Quick Ratio of 5.99 is 216.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current Quick Ratio is 5.99, which is 90% below median its own 10-year median of 59.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (BLOZF) has a current Quick Ratio of 5.99. The current Quick Ratio is 5.99, which is 90% below median its 10-year median of 59.08 and 216.9% above the Medical Devices & Instruments industry median of 1.89. Cannabix Technologies' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Cannabix Technologies (BLOZF), the current Quick Ratio is 5.99 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
34GF Score
Get the complete analysis for BLOZF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLOZF has been successfully added to your 
